In GBM, the expression of BST2 was negatively correlated with CD8+ T cells (correlation coefficient −0.152), while the expression of BST2 in low grade glioma was positively correlated with CD8+ T cells (correlation coefficient 0.226) (Figures 6D,E). Here, BST2 is linked to central nervous system cancer.